296 related articles for article (PubMed ID: 26767515)
1. Superparamagnetic iron-oxide nanoparticles mPEG350- and mPEG2000-coated: cell uptake and biocompatibility evaluation.
Silva AH; Lima E; Mansilla MV; Zysler RD; Troiani H; Pisciotti MLM; Locatelli C; Benech JC; Oddone N; Zoldan VC; Winter E; Pasa AA; Creczynski-Pasa TB
Nanomedicine; 2016 May; 12(4):909-919. PubMed ID: 26767515
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: magnetic targeting.
Mojica Pisciotti ML; Lima E; Vasquez Mansilla M; Tognoli VE; Troiani HE; Pasa AA; Creczynski-Pasa TB; Silva AH; Gurman P; Colombo L; Goya GF; Lamagna A; Zysler RD
J Biomed Mater Res B Appl Biomater; 2014 May; 102(4):860-8. PubMed ID: 24458920
[TBL] [Abstract][Full Text] [Related]
3. Influence of Surface Charge and Polymer Coating on Internalization and Biodistribution of Polyethylene Glycol-Modified Iron Oxide Nanoparticles.
Maurizi L; Papa AL; Dumont L; Bouyer F; Walker P; Vandroux D; Millot N
J Biomed Nanotechnol; 2015 Jan; 11(1):126-36. PubMed ID: 26301306
[TBL] [Abstract][Full Text] [Related]
4. Theranostic MUC-1 aptamer targeted gold coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging and photothermal therapy of colon cancer.
Azhdarzadeh M; Atyabi F; Saei AA; Varnamkhasti BS; Omidi Y; Fateh M; Ghavami M; Shanehsazzadeh S; Dinarvand R
Colloids Surf B Biointerfaces; 2016 Jul; 143():224-232. PubMed ID: 27015647
[TBL] [Abstract][Full Text] [Related]
5. Effect of PEG molecular weight on stability, T₂ contrast, cytotoxicity, and cellular uptake of superparamagnetic iron oxide nanoparticles (SPIONs).
Park YC; Smith JB; Pham T; Whitaker RD; Sucato CA; Hamilton JA; Bartolak-Suki E; Wong JY
Colloids Surf B Biointerfaces; 2014 Jul; 119():106-14. PubMed ID: 24877593
[TBL] [Abstract][Full Text] [Related]
6. One-pot facile synthesis of PEGylated superparamagnetic iron oxide nanoparticles for MRI contrast enhancement.
Dai L; Liu Y; Wang Z; Guo F; Shi D; Zhang B
Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():161-7. PubMed ID: 24907749
[TBL] [Abstract][Full Text] [Related]
7. Surface modification of superparamagnetic iron oxide (SPION) and comparison of cytotoxicity effect of mPEG2000-PEI-SPION and mPEG750-PEI-SPION on the human embryonic carcinoma stem cell, NTERA2 cell line.
Sadeghi Z; Maleki P; Shahabi F; Bondarkhilli SAM; Masoumi M; Taheri M; Mohammadi M; Raheb J
Hum Antibodies; 2020; 28(2):159-167. PubMed ID: 32116243
[TBL] [Abstract][Full Text] [Related]
8. Selection of potential iron oxide nanoparticles for breast cancer treatment based on in vitro cytotoxicity and cellular uptake.
Poller JM; Zaloga J; Schreiber E; Unterweger H; Janko C; Radon P; Eberbeck D; Trahms L; Alexiou C; Friedrich RP
Int J Nanomedicine; 2017; 12():3207-3220. PubMed ID: 28458541
[TBL] [Abstract][Full Text] [Related]
9. Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging.
Unterweger H; Janko C; Schwarz M; Dézsi L; Urbanics R; Matuszak J; Őrfi E; Fülöp T; Bäuerle T; Szebeni J; Journé C; Boccaccini AR; Alexiou C; Lyer S; Cicha I
Int J Nanomedicine; 2017; 12():5223-5238. PubMed ID: 28769560
[TBL] [Abstract][Full Text] [Related]
10. Targeted delivery of paclitaxel drug using polymer-coated magnetic nanoparticles for fibrosarcoma therapy: in vitro and in vivo studies.
Al-Obaidy R; Haider AJ; Al-Musawi S; Arsad N
Sci Rep; 2023 Feb; 13(1):3180. PubMed ID: 36823237
[TBL] [Abstract][Full Text] [Related]
11. Development of superparamagnetic iron oxide nanoparticles via direct conjugation with ginsenosides and its in-vitro study.
Singh H; Du J; Singh P; Mavlonov GT; Yi TH
J Photochem Photobiol B; 2018 Aug; 185():100-110. PubMed ID: 29885646
[TBL] [Abstract][Full Text] [Related]
12. Glucose-coated superparamagnetic iron oxide nanoparticles prepared by metal vapor synthesis can target GLUT1 overexpressing tumors: In vitro tests and in vivo preliminary assessment.
Barbaro D; Di Bari L; Gandin V; Marzano C; Ciaramella A; Malventi M; Evangelisti C
PLoS One; 2022; 17(6):e0269603. PubMed ID: 35704647
[TBL] [Abstract][Full Text] [Related]
13. Toxicity assessment of superparamagnetic iron oxide nanoparticles in different tissues.
Vakili-Ghartavol R; Momtazi-Borojeni AA; Vakili-Ghartavol Z; Aiyelabegan HT; Jaafari MR; Rezayat SM; Arbabi Bidgoli S
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):443-451. PubMed ID: 32024389
[TBL] [Abstract][Full Text] [Related]
14. Superparamagnetic iron oxide nanoparticle uptake alters M2 macrophage phenotype, iron metabolism, migration and invasion.
Rojas JM; Sanz-Ortega L; Mulens-Arias V; Gutiérrez L; Pérez-Yagüe S; Barber DF
Nanomedicine; 2016 May; 12(4):1127-1138. PubMed ID: 26733263
[TBL] [Abstract][Full Text] [Related]
15. Polyethylene Glycol-Chitosan Oligosaccharide-Coated Superparamagnetic Iron Oxide Nanoparticles: A Novel Drug Delivery System for Curcumin Diglutaric Acid.
Sorasitthiyanukarn FN; Muangnoi C; Thaweesest W; Bhuket PRN; Jantaratana P; Rojsitthisak P; Rojsitthisak P
Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31906490
[TBL] [Abstract][Full Text] [Related]
16. Polymeric Reactor for the Synthesis of Superparamagnetic-Thermal Treatment of Breast Cancer.
Alhasan AH; Fardous RS; Alsudir SA; Majrashi MA; Alghamdi WM; Alsharaeh EH; Almalik AM
Mol Pharm; 2019 Aug; 16(8):3577-3587. PubMed ID: 31291120
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution and Clearance of Stable Superparamagnetic Maghemite Iron Oxide Nanoparticles in Mice Following Intraperitoneal Administration.
Pham BTT; Colvin EK; Pham NTH; Kim BJ; Fuller ES; Moon EA; Barbey R; Yuen S; Rickman BH; Bryce NS; Bickley S; Tanudji M; Jones SK; Howell VM; Hawkett BS
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29320407
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and Characterization of Citrate-Stabilized Gold-Coated Superparamagnetic Iron Oxide Nanoparticles for Biomedical Applications.
Stein R; Friedrich B; Mühlberger M; Cebulla N; Schreiber E; Tietze R; Cicha I; Alexiou C; Dutz S; Boccaccini AR; Unterweger H
Molecules; 2020 Sep; 25(19):. PubMed ID: 32993144
[TBL] [Abstract][Full Text] [Related]
19. Targeting experimental orthotopic glioblastoma with chitosan-based superparamagnetic iron oxide nanoparticles (CS-DX-SPIONs).
Shevtsov M; Nikolaev B; Marchenko Y; Yakovleva L; Skvortsov N; Mazur A; Tolstoy P; Ryzhov V; Multhoff G
Int J Nanomedicine; 2018; 13():1471-1482. PubMed ID: 29559776
[TBL] [Abstract][Full Text] [Related]
20. Optimizing superparamagnetic iron oxide nanoparticles as drug carriers using an in vitro blood-brain barrier model.
Shi D; Mi G; Bhattacharya S; Nayar S; Webster TJ
Int J Nanomedicine; 2016; 11():5371-5379. PubMed ID: 27799764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
